Tutorials
Assembly Biosciences Inc logo

Assembly Biosciences Inc

$ 2.13 -0.03 (-1.39%) 10:08 PM EST
P/E:
At Loss
P/B:
0.69
Market Cap:
$ 102.70M
Enterprise V:
$ -13.15M
Volume:
315.90K
Avg Vol (2M):
517.60K
Also Trade In:
Volume:
315.90K
Market Cap $:
102.70M
PE Ratio:
At Loss
Avg Vol (2-Month):
517.60K
Enterprise Value $:
-13.15M
PB Ratio:
0.69
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Assembly Biosciences Inc
NAICS : 325412 SIC : 2834
331 Oyster Point Boulevard, Fourth Floor, South San Francisco, CA, USA, 94080
Description
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
Name Current Vs Industry Vs History
Cash-To-Debt 21.56
Equity-to-Asset 0.9
Debt-to-Equity 0.04
Debt-to-EBITDA -0.07
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.39
Distress
Grey
Safe
Beneish M-Score 21.82
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 52.81
9-Day RSI 51.15
14-Day RSI 51.57
6-1 Month Momentum % 27.54
12-1 Month Momentum % -41.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.21
Quick Ratio 12.21
Cash Ratio 11.49
Days Sales Outstanding 24.85

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -23.6

Financials (Next Earnings Date:2022-11-04 Est.)

ASMB's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ASMB

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 6.254
EPS (TTM) ($) -2.81
Beta 0.46
Volatility % 57.48
14-Day RSI 51.57
14-Day ATR ($) 0.124186
20-Day SMA ($) 2.123
12-1 Month Momentum % -41.8
52-Week Range ($) 1.3199 - 3.94
Shares Outstanding (Mil) 48.22

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Assembly Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More